Percutaneous balloon occlusion of a left ventricular assist device outflow cannula to facilitate evaluation of myocardial recovery

Abstract

with sub-optimal post-transplant outcome. The background issue is one of balance between patient and graft survival. An attractive option that addresses this issue is a heart allocation system based on calculated survival benefit, the increment in lifetime with the transplantation compared to without transplantation. However, as others have pointed out, the use of risk factors as prognostic variables for estimation of individual survival may be disappointing. In 2010, some variables that could predict risk of waiting list and post-transplant death were included in the database maintained by L’Agence de la biomedecine, and a prospective study designed to evaluate the feasibility and usefulness of estimation of individual survival benefit was launched. All patients listed between January 2010 and December 2011 will be included and followed up for 1 year after listing and/or transplantation. The results will be available in 2014.